4-[4-(4,4,5-TRIMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENYL]-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER, 90.0%, 250mg

3-Bromo-N-(piperidin-4-yl)benzenesulfonamide hydrochloride, 95.0%, 1g

(11bR)-4-Hydroxy-2,6-bis(perfluorophenyl)-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide, 250mg

3-Phenylquinoxaline-5-carboxylic acid, 95.0%, 1g

N-(2,3-dihydro-1H-inden-5-yl)acetamide, 95+%, 5g

(4S,4'S)-2,2'-(1,3-Bis(4-(tert-butyl)phenyl)propane-2,2-diyl)bis(4-methyl-4,5-dihydrooxazole), 97%, 250mg

N-(2-phenylethyl)-4-piperidinecarboxamide dihydrochloride, 95.0%, 5g

4-Pentyloxyphthalonitrile>98.0%(GC)1g

2,3-Dimethylbutan-2-ol, 98%, 5g

N-(6-Aminohexyl)maleimide Hydrochloride>98.0%(HPLC)(T)250mg

2,6-Dichloro-5-fluoronicotinamide, 95.0%, 1g

METHYL 5-BROMO-3-FLUORO-2-METHYLBENZOATE, 95.0%, 1g

1-(2-Chloro-4-nitrophenyl)ethanone, 95.0%, 1g